Company Analysis

Innate Pharma S.A. (IPHA)

Nasdaq: IPHA · Biological Products, (No Diagnostic Substances) · Marseille · filing with the SEC since 2014
Grade4.3
◀ Past 5.9● Present 4.0▶ Future 3.5
2 est.

Who runs Innate Pharma S.A.

The record holds no Form 3, 4 or 5 for this company yet, so no officer or director is named.
SI Assistanton IPHA · research, not advice